Clinical trial
Safety and Tolerability of High Dose Biotin in Patients With Amyotrophic Lateral Sclerosis
NCT03427086 is registered in ClinicalTrials.gov with American University of Beirut Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Tolerability of High Dose Biotin in Patients With Amyotrophic Lateral Sclerosis
- Lead sponsor
- American University of Beirut Medical Center
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- January 29, 2018
- Completion date
- May 10, 2021
- Enrollment
- 12 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.